I'd like to know what are we actually selling? Every opportunity so far sounds like a clinical trial without material commercial opportunity.
How did we get involved in selling that cough counting app? Someone got caught in the lights of a big pharma logo.
The answer regarding who is selling our "product" was concerning:
Tony stated that we now have Mike Connell (VP commercial) - Who has 2x new "Sales & marketing" hires.. How many people with marketing backgrounds have pharma or clinical experience (let alone contacts)?
I'd like to know out of the 30 opportunities being progressed, how many approached ResApp? I'd prefer a boots on the ground BDM (with pharma contacts) rather than someone in marketing positioning us for inbound leads. We don't have a brand.. yet.
- Forums
- ASX - By Stock
- RAP
- Ann: Quarterly Activities Report and Appendix 4C
Ann: Quarterly Activities Report and Appendix 4C, page-10
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online